SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001558370-16-006418
Filing Date
2016-06-17
Accepted
2016-06-17 16:07:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 acrs-20160617xs1.htm S-1 436329
2 acrs-20160617ex51ce04b29.htm EX-5.1 16211
3 acrs-20160617ex102513ade.htm EX-10.25 31140
4 acrs-20160617ex21165f894.htm EX-21.1 5490
5 acrs-20160617ex2310e450c.htm EX-23.1 4330
6 acrs20160617xs1001.jpg GRAPHIC 5731
7 acrs20160617ex51ce04b29001.jpg GRAPHIC 4331
  Complete submission text file 0001558370-16-006418.txt   508609
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-212095 | Film No.: 161720219
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences